Dymon Asia Capital »

Viking Therapeutics shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $317k 5.0k 63.31

More positions owned by Dymon Asia Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci India Sm Cp Put Option (SMIN)
Target Corporation Call Option (TGT)
Nextera Energy Call Option (NEE)
3M Company Call Option (MMM)
Kanzhun Sponsored Ads (BZ)
Arm Holdings Sponsored Ads Call Option (ARM)
Sea Sponsord Ads Call Option (SE)
Lauder Estee Cos Cl A Call Option (EL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Dollar General (DG)
Air Products & Chemicals Call Option (APD)
Oracle Corporation Call Option (ORCL)
salesforce Call Option (CRM)
United Parcel Service CL B Call Option (UPS)

View all positions for Dymon Asia Capital

Top funds holding Viking Therapeutics

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Susquehanna International
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Perpetual
Alliancebernstein
Goldman Sachs Group
Braidwell
Jane Street

View all funds holding Viking Therapeutics